Metoclopramide Dosing and Management in Adolescents with Functional Gastroparesis
Initial Dosing Recommendations
Dose‑Titration Range
Treatment‑Duration Limitation
Pre‑treatment Assessment
Dietary Optimization
Objective Confirmation of Delayed Gastric Emptying
Alternative Therapies When Metoclopramide Is Ineffective or Not Tolerated
Antiemetic Options
Domperidone as a CNS‑Sparing Pro‑kinetic
Metoclopramide's Role in Treating Gastrointestinal Motility Disorders
Mechanism of Action and Clinical Applications
- The American Gastroenterological Association recommends metoclopramide as a first-line therapy for gastroparesis, with a recommended dosage of 5-20 mg three to four times daily before meals, due to its dual mechanism of stimulating gastric motility via acetylcholine release and blocking dopamine receptors 3
- The European Medicines Agency's Committee recommends against long-term use of metoclopramide due to risk of extrapyramidal side effects, and the FDA has issued a black box warning against use beyond 12 weeks 4, 5, 6
Alternative Treatments and Treatment Algorithm
- The American Diabetes Association suggests dietary modifications, such as a low-fiber, low-fat eating plan with small frequent meals, as a first-line approach for treating gastroparesis, and metoclopramide 5-10 mg orally three times daily before meals (not to exceed 12 weeks) as a pharmacological intervention 3, 4
- For refractory cases, consider endoscopic, surgical, or electrical stimulation options, and enteral feeding may be necessary in extreme cases 3, 7